Panunto Patrícia C, da Silva Maura A, Linardi Alessandra, Buzin Marta P, Melo Silvia E S F C, Mello Sueli M, Prado-Franceschi Julia, Hyslop Stephen
Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), CP 6111, 13083-970 Campinas, SP, Brazil.
Toxicon. 2006 Jan;47(1):21-31. doi: 10.1016/j.toxicon.2005.08.012. Epub 2005 Nov 23.
Snake venoms contain saccharide-binding lectins. In this work, we examined the biological activities of a lectin (BjcuL) purified from Bothrops jararacussu snake venom by chromatography on non-derivatized Sepharose 4B and Sephacryl S-200 HR. The protein, a homodimer with subunits of 14.5 kDa, gave a single immunoprecipitin line in immunoelectrophoresis and cross-reacted in ELISA with antivenoms raised against Bothrops spp. (lanceheads), Micrurus spp. (coral snakes), Crotalus durissus terrificus (South American rattlesnake), and arthropod (Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus) venoms. BjcuL agglutinated human formaldehyde-fixed erythrocytes at > or = 100 ng/ml and was inhibited by lactose and EDTA (> or = 2 mM) and high concentrations (> 100 mM) of glucose and sucrose, but not by N-acetylglucosamine. BjcuL had no direct hemolytic activity and was devoid of esterase, PLA2 and proteolytic activities. The lectin (up to 200 microg/ml) did not aggregate human platelet-rich plasma (PRP) or washed platelets (WP), nor did it alter the aggregation induced by ADP in PRP or by thrombin in WP. When injected into mouse hind paws, BjcuL (10-100 microg/paw) caused edema and increased vascular permeability, with a maximum effect after 1h that persisted for up to 6 h (edema) or gradually decreased after the peak interval (vascular permeability). No hemorrhage was observed in BjcuL-injected paws. In anesthetized rats, B. jararacussu venom (200 microg/kg, i.v.) produced sustained hypotension (maximum decrease of approximately 60%) whereas a similar dose of BjcuL decreased the blood pressure by approximately 15%, with a rapid return to the resting level.
蛇毒中含有糖类结合凝集素。在本研究中,我们通过在未衍生化的琼脂糖凝胶4B和Sephacryl S - 200 HR上进行层析,检测了从巴西矛头蝮蛇毒中纯化得到的一种凝集素(BjcuL)的生物学活性。该蛋白质是一种由14.5 kDa亚基组成的同型二聚体,在免疫电泳中产生单一免疫沉淀线,并且在ELISA中与针对巴西矛头蝮属(矛头蝮)、珊瑚蛇属(珊瑚蛇)、南美响尾蛇(南美响尾蛇)以及节肢动物(巴西游走蛛、黑腹捕鸟蛛和巴西黄蝎)毒液产生的抗蛇毒血清发生交叉反应。BjcuL在浓度≥100 ng/ml时可凝集人甲醛固定红细胞,其凝集作用受到乳糖和EDTA(≥2 mM)以及高浓度(>100 mM)葡萄糖和蔗糖的抑制,但不受N - 乙酰葡糖胺的抑制。BjcuL没有直接溶血活性,也没有酯酶、磷脂酶A2和蛋白水解活性。该凝集素(浓度高达200 μg/ml)不会使富含人血小板的血浆(PRP)或洗涤后的血小板(WP)聚集,也不会改变PRP中ADP诱导的聚集或WP中凝血酶诱导的聚集。当注射到小鼠后爪时,BjcuL(10 - 100 μg/爪)会引起水肿并增加血管通透性,1小时后达到最大效应,水肿可持续长达6小时,血管通透性在达到峰值后逐渐下降。在注射BjcuL的爪子中未观察到出血现象。在麻醉大鼠中,巴西矛头蝮蛇毒(200 μg/kg,静脉注射)会导致持续性低血压(最大降幅约为60%),而相同剂量的BjcuL使血压降低约15%,随后迅速恢复到静息水平。